EU/3/16/1818 - orphan designation for treatment of acute liver failure

Name: EU/3/16/1818 - orphan designation for treatment of acute liver failure
Creator: European Medicines Agency
Keywords: cells,designation,orphan,summaries,treatment

Information

Original link

Type

Miscellaneous

Regulated products

Medical Devices

Last updated

July 14, 2017

Description

Orphan designation granted for EU/3/16/1818, a treatment for acute liver failure.

Organization

European Medicines Agency (EMA) 🇪🇺

Country / Region

European Union

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

1 Main file

EU/3/16/1818: Public summary of opinion on orphan designation: Human hepatoma cell line HepaRG in bioartificial liver for the treatment of acute liver failure

Updated on July 14, 2017

pdf

URL: https://www.ema.europa.eu/en/documents/orphan-designation/eu3161818-public-summary-opinion-orphan-designation-human-hepatoma-cell-line-heparg-bioartificial-liver-treatment-acute-liver-failure_en.pdf
Permalink: https://data.openrid.co/en/datasets/r/cd486886-3998-42dd-9a15-14ecb28e6505
MIME Type: application/pdf

Created on: July 14, 2017
Modified on: July 14, 2017

EMA/3424/2017